Chargement en cours...
The Effects of RANKL Inhibition on Fracture Healing and Bone Strength in a Mouse Model of Osteogenesis Imperfecta
Currently, the standard treatment for osteogenesis imperfecta (OI) is bisphosphonate therapy. Recent studies, however, have shown delayed healing of osteotomies in a subset of OI patients treated with such agents. The current study sought to determine the effects of another therapy, RANKL inhibition...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2008
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2672306/ https://ncbi.nlm.nih.gov/pubmed/17729310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jor.20469 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|